Aspect Biosystems

Meet an Unreasonable Venture

Creating bioprinted tissue therapeutics to transform how we treat some of the most elusive diseases

Tamer Mohamed

Founder and CEO at Aspect Biosystems

More about Tamer »

Connect

aspectbiosystems.com

Employees 101–200

Headquarters Vancouver, British Columbia, Canada

Aspect Biosystems is a biotechnology company pioneering the development of bioprinted tissue therapeutics to transform how we treat some of the most elusive diseases. Aspect’s bioprinted tissue therapeutics are designed to replace, repair, or supplement biological function inside the body. Aspect is creating these next-generation cell therapies by applying its full-stack tissue therapeutic platform, which integrates proprietary AI-powered bioprinting technology, computational design tools, therapeutic cells, and advanced biomaterials. Aspect is advancing a pipeline of bioprinted tissue therapeutics across multiple disease areas in the endocrine and metabolic space including diabetes, obesity, rare endocrine disorders, and liver disease.

Health

Notable Achievements

Raised over US$260 million in capital
Entered partnership with healthcare leader Novo Nordisk to develop therapies for diabetes and obesity
Named to Fast Company's list of Next Big Things in Tech & Biotech Company of the Year by BIOTECanada

Currently Operating in One Region

Elevator Pitch

Subscribe for More Videos »

Press Mentions

January 13, 2025

Game-Changing $115M for Aspect Biosystems’ Bioprinted Tech - 3DPrint.com

Aspect Biosystems has successfully raised $115 million in a Series B financing round, enhancing its capabilities in bioprinted tissue therapeutics. This funding positions the company to advance its...

Read on sp3d »

January 8, 2025

Vancouver’s Aspect Biosystems raises $115-million to develop 3-D printed human tissue technology

Aspect Biosystems has successfully raised $115 million in Series B financing to advance its innovative 3D bioprinting technology for tissue therapeutics. This funding will enhance their...

Read on The Globe and Mail »

September 20, 2024

11 Canadian tech companies to watch in 2020 - ImHecate

Aspect Biosystems is celebrated for its groundbreaking advancements in bioprinting technology, revolutionizing tissue engineering. Recognized as a top Canadian tech company to watch in 2020, it...

Read on ImHecate »

July 11, 2024

Aspect Biosystems gets over $70 million in government investment to continue innovative work - BC Business

Aspect Biosystems secures a $200 million partnership with the governments of Canada and British Columbia for bioprinted tissue therapeutics. The investment aims to drive biotech innovation in...

Read on BC Business »

July 10, 2024

$200 million federal, BC & tech partnership partnership in bioprinted tissue therapeutics - Island Social Trends

Canada and British Columbia partner in a $200 million deal with Aspect Biosystems to advance bioprinted tissue therapeutics. The collaboration aims to revolutionize healthcare by developing...

Read on Island Social Trends »

November 29, 2023

Aspect Biosystems Named to Fast Company's 2023 List of the Next Big Things in Tech

Aspect Biosystems, a biotech company specializing in 3D bioprinting, has been recognized by Fast Company as one of the world's most innovative companies for its advancements in creating functional...